Lung Cancer Surgery in India Trends and Forecast
The future of the lung cancer surgery market in India looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2031 with a CAGR of 3.4% from 2025 to 2031. The lung cancer surgery market in India is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising occurrence of lung cancer, the increasing consumer preference towards minimally invasive surgeries, and the growing air pollution levels.
• Lucintel forecasts that, within the product type category, surgical device is expected to witness the highest growth over the forecast period.
• Within the end use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
Emerging Trends in the Lung Cancer Surgery Market in India
India is experiencing a notable transformation in lung cancer surgery, driven by rising incidence, growing public awareness, and increasing access to specialized oncology care. Government and private healthcare providers are investing in early detection and surgical infrastructure. Surgeons are moving toward minimally invasive and personalized treatment approaches. With improved diagnostic capabilities and a growing ecosystem of cancer care networks, India is fostering an environment that supports advanced surgical interventions aimed at better survival outcomes and reduced recovery times for lung cancer patients.
• Rise of Minimally Invasive Thoracic Surgeries: The shift from traditional open thoracotomy to VATS and robotic-assisted thoracic surgery is gaining momentum in India. These techniques offer reduced postoperative pain, faster recovery, and fewer complications. Hospitals in metros and Tier-1 cities are adopting this trend to improve patient satisfaction and decrease ICU stay duration. It also aligns with the increasing preference for less invasive approaches among younger and urban patients seeking advanced care options for lung cancer.
• Expansion of Private Cancer Hospital Networks: Private multispecialty and oncology-dedicated hospitals are expanding their surgical oncology wings, including advanced thoracic units. These facilities are equipped with cutting-edge imaging and surgical technology, enabling complex resections and lobectomies. The rise of chain hospitals improves accessibility to expert care across India. These centers also attract medical tourists and offer affordable, high-quality lung cancer surgeries, driving growth in both domestic and international markets.
• Integration of Molecular Diagnostics in Surgical Decision-Making: Molecular profiling and genetic testing are increasingly used to tailor surgical decisions in India. While more commonly associated with targeted drug therapy, these insights now guide decisions on surgery eligibility and extent, especially in cases with actionable mutations. Surgeons collaborate with oncologists to develop personalized treatment plans, ensuring optimal outcomes and minimizing unnecessary surgical interventions for non-surgical candidates.
• Growth of Public-Private Partnerships in Cancer Care: India is seeing a rise in collaborations between government bodies and private healthcare providers to enhance cancer care infrastructure. These partnerships focus on improving access to surgical interventions in underserved areas, with emphasis on subsidized surgeries, training of thoracic surgeons, and equipment modernization. Such models are helping bridge care disparities between rural and urban populations and improving national surgical outcomes for lung cancer.
• Increased Surgeon Training and Sub specialization: Medical colleges and tertiary hospitals are introducing dedicated thoracic oncology fellowships and international exchange programs. This trend is helping to build a cadre of specialists skilled in lung cancer surgery, especially in minimally invasive techniques. Improved surgeon competency supports standardization of care across regions. As thoracic surgery gains recognition as a critical subspecialty, more surgeons are pursuing focused training, strengthening India‘s surgical capacity in oncology.
India’s lung cancer surgery landscape is evolving with the adoption of minimally invasive techniques, expansion of private care networks, and integration of molecular insights. With government initiatives and skill development programs accelerating innovation, the market is shifting toward accessible, high-quality, and patient-centered surgical care. These trends are enabling more precise, faster, and equitable lung cancer treatment across urban and emerging healthcare centers.
Recent Developments in the Lung Cancer Surgery Market in India
India’s lung cancer surgery domain is witnessing rapid advancements supported by policy incentives, rising cancer centers, and cross-specialty collaboration. The focus is on upgrading diagnostics, integrating robotics, and decentralizing care. These developments aim to address the country’s rising lung cancer burden through surgical capacity building, infrastructure investments, and patient-friendly innovations. Together, these changes are enhancing access, reducing surgical risk, and creating a robust pipeline of solutions for future growth in India’s lung cancer surgery market.
• Launch of Robotic Surgery Platforms in Tier-2 Cities: Leading hospital chains have introduced robotic-assisted thoracic surgery units in cities like Pune, Coimbatore, and Lucknow. These centers are helping decentralize advanced cancer care and improve surgical precision beyond metro cities. The expansion reduces patient migration to urban hubs and broadens access to minimally invasive procedures, particularly lobectomies and segmentectomies. It also fosters local talent development and regional health system strengthening.
• Establishment of Government-Funded Cancer Institutes: Several new regional cancer centers supported by the Indian government are being set up with surgical oncology as a focus. These institutes provide subsidized care, screening programs, and thoracic surgery services, especially in the northeast and central regions. This initiative supports care equity by increasing access to surgical intervention for underserved populations and strengthening early-stage lung cancer treatment infrastructure nationwide.
• Adoption of Enhanced Recovery After Surgery (ERAS) Protocols: Hospitals are incorporating ERAS protocols into thoracic surgery programs to reduce complications and hospital stays. These include preoperative counseling, pain control regimens, and early mobilization strategies. In India, ERAS improves outcomes and operational efficiency in high-volume centers, particularly private hospitals. The protocol is contributing to shorter recovery periods and lower costs, making lung cancer surgery more manageable and accessible.
• Implementation of AI-Assisted Diagnostic Imaging: AI-enabled imaging platforms for lung nodule detection and surgical planning are being trialed in leading Indian hospitals. These tools help improve detection accuracy and assist in surgical decision-making. With growing interest in precision medicine, these solutions are streamlining workflows and supporting multidisciplinary teams in managing complex cases. AI’s growing role in diagnostics is gradually improving pre-surgical staging and reducing avoidable interventions.
• Increased Funding for Surgical Research and Innovation: Indian institutions are receiving grants to research indigenous surgical tools, thoracoscopic techniques, and post-operative recovery models. This funding is facilitating clinical trials, device innovation, and outcome monitoring tailored to India’s healthcare needs. It enables the development of cost-effective surgical solutions adapted for low-resource settings, improving the reach and sustainability of lung cancer surgery services across the country.
Recent developments in India’s lung cancer surgery market reflect strong momentum in capacity building, innovation, and equitable access. Robotic surgery expansion, AI-driven diagnostics, and enhanced recovery protocols are transforming patient experiences and clinical workflows. As the government and private sector collaborate to scale infrastructure and improve regional access, these advancements are reshaping India’s surgical landscape and establishing a more resilient cancer care framework.
Strategic Growth Opportunities for Lung Cancer Surgery Market in India
India is witnessing a rising demand for lung cancer surgery due to an increase in early-stage diagnosis, improved healthcare access, and a growing aging population. Advances in surgical techniques and investment in oncology infrastructure are creating strong momentum across urban centers. As awareness of lung cancer symptoms improves and screening efforts expand, hospitals are preparing to meet demand with minimally invasive procedures and improved care models. These changes are enabling key application-based opportunities for market participants.
• Growth in Video-Assisted Thoracoscopic Surgery: Video-assisted thoracoscopic surgery is becoming a preferred approach in Indian oncology centers for its low invasiveness and better recovery outcomes. With more patients detected in early stages due to growing awareness, hospitals are shifting toward VATS lobectomy and wedge resections. Surgeons benefit from shorter operation times and enhanced visibility. Providers offering compact VATS instruments and mobile training units can expand into secondary cities where thoracic surgery is limited. As VATS reduces hospitalization costs, it aligns with hospital cost-saving targets and benefits from growing insurance coverage.
• Expansion of Robotic-Assisted Thoracic Surgery Programs: Leading Indian hospitals in metro areas are investing in robotic-assisted surgery to improve thoracic precision and patient recovery. These systems help reduce blood loss and complications. Demand is supported by increasing referrals from Tier 2 and Tier 3 cities. Suppliers offering bundled service packages with installation, surgeon training, and financing support are gaining traction. Robotic systems are being promoted in medical tourism centers where precision and reputation matter. Opportunities lie in scalable deployment models for broader national reach.
• Early Detection Driving Surgical Volume: Government health campaigns and private screening initiatives are resulting in earlier detection of lung cancers. With early diagnosis, more patients are eligible for surgical intervention rather than palliative care. Hospitals are streamlining diagnosis-to-surgery pathways, increasing demand for efficient surgical tools and planning systems. Startups providing AI-based diagnostic support or fast-track triage tools can integrate into oncology networks. Increased volume also encourages investment in surgical capacity, creating demand for modular operating rooms and multidisciplinary teams.
• Postoperative Telemonitoring and Remote Care Models: India’s lung surgery patients often return to rural areas post-discharge, making in-person follow-ups difficult. Telemedicine and home-monitoring platforms are increasingly used to track symptoms, oxygen levels, and recovery metrics remotely. Devices that enable digital rehabilitation and AI-driven alerts are in demand among urban hospitals managing large patient networks. Companies providing remote monitoring kits with app-based support can help reduce readmissions and support care in underserved regions. These systems enable continuity of care while reducing hospital burden.
• Surge in Oncology-Focused Medical Tourism: India’s high-quality cancer surgery programs attract international patients from South Asia, Africa, and the Middle East. Competitive pricing, short wait times, and advanced thoracic surgical options make India a preferred destination. Hospitals are promoting minimally invasive and robotic lung cancer surgeries in medical tourism packages. Medical device firms and service providers offering support in patient experience, translation, and logistics can enhance this offering. Partnerships with global facilitators can further expand international patient flow to India.
India’s lung cancer surgery market is expanding through VATS adoption, robotic programs, early diagnosis, telehealth monitoring, and international medical travel. These opportunities reflect a broader shift toward efficiency, patient-centric care, and global competitiveness. Hospitals and suppliers that focus on accessibility, technology integration, and multidisciplinary approaches will thrive in this evolving environment.
Lung Cancer Surgery Market in India Driver and Challenges
The lung cancer surgery market in India is shaped by technological advancement, demographic shifts, and growing public-private healthcare infrastructure. Strong demand is fueled by early diagnosis, increased surgical expertise, and expanding tertiary hospital access. However, challenges related to affordability, uneven regional access, and workforce gaps persist. Understanding and navigating these dynamics is essential for sustained market engagement and strategic innovation.
The factors responsible for driving the lung cancer surgery market in India include:
• Rising Early Diagnosis and Awareness: Government-led awareness programs and private diagnostic chains are encouraging earlier detection of lung cancer. Improved knowledge of symptoms and risks is increasing the number of stage I and II cancer cases eligible for surgical treatment. Patients and physicians are also more willing to seek advanced interventions. This trend creates sustained demand for minimally invasive procedures and boosts investment in thoracic surgery infrastructure across major hospitals and cancer centers.
• Strengthening Healthcare Infrastructure in Tier 2 Cities: India is witnessing rapid development of multispecialty hospitals in Tier 2 cities where demand for oncology care is surging. With government incentives and private sector expansion, these hospitals are upgrading facilities to offer advanced thoracic surgery. Vendors targeting regional hospitals with affordable surgical systems and scalable support packages are gaining access to a fast-growing segment. This decentralization also improves patient accessibility and surgical outcomes across diverse regions.
• Growth in Private Insurance and Reimbursement Coverage: Private health insurance penetration is rising in India, improving affordability for complex surgeries. Many policies now cover robotic and thoracoscopic lung procedures. This expansion allows hospitals to invest in advanced surgical systems and offer more inclusive care packages. Insurance providers are increasingly partnering with accredited hospitals to streamline pre-approvals and post-surgical support. These changes reduce out-of-pocket expenses and encourage patients to opt for timely surgical care.
• Improved Training and Skill Development: Medical institutions and device companies are investing in thoracic surgery training programs, improving surgeon proficiency in VATS and robotic-assisted procedures. Fellowship programs and simulation labs are growing in academic centers, leading to wider adoption of minimally invasive methods. Surgeons with advanced skillsets are more willing to upgrade techniques, improving patient safety and outcomes. Vendors that align products with educational initiatives gain acceptance through clinical validation and knowledge sharing.
• Technological Innovations in Imaging and Planning: AI-powered imaging platforms, 3D surgical planning tools, and intraoperative navigation systems are enabling more accurate resections. Hospitals are adopting these tools to reduce surgical risks and support personalized care. Companies that integrate imaging with surgical workflow stand to gain competitive advantage. These technologies are particularly valuable in complex resections and recurrent tumor surgeries, where precision is essential to avoid complications and preserve lung function.
Challenges in the lung cancer surgery market in India are:
• Affordability and Out-of-Pocket Burden: Despite expanding insurance, a large proportion of patients still pay out-of-pocket for lung surgery. High costs for robotic systems and surgical consumables limit access to advanced care. Providers must offer flexible financing, public-private partnerships, or value-based models to address this affordability gap. Without cost containment strategies, even technologically equipped hospitals may struggle to offer these procedures to the majority population.
• Disparities in Rural Access and Facility Gaps: While metro hospitals have advanced thoracic units, rural areas face shortages of trained specialists and surgical infrastructure. Patients often travel long distances for diagnosis and treatment, delaying care. Government programs and mobile surgery initiatives can help bridge this divide. Companies must design tools that are transportable, easy to operate, and require minimal training to function effectively in remote settings.
• Limited Postoperative Support and Monitoring: Follow-up care remains inconsistent in India, especially for patients returning to rural areas post-surgery. Lack of structured rehabilitation, symptom monitoring, and counseling increases the risk of readmission. Hospitals and providers must invest in telehealth, mobile health units, and community-based follow-up models to ensure continuity of care. Companies offering scalable digital platforms can address this unmet need and improve recovery outcomes.
India’s lung cancer surgery market is being reshaped by growing diagnosis, improved infrastructure, insurance support, and technology integration. However, affordability and access remain critical challenges. Balancing innovation with cost-efficiency, regional reach, and patient education will determine long-term success for stakeholders in this evolving market.
List of Lung Cancer Surgery Market in India Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, lung cancer surgery companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Lung Cancer Surgery Market in India by Segment
The study includes a forecast for the lung cancer surgery market in India by product type, surgery, and end use.
Lung Cancer Surgery Market in India by Product Type [Analysis by Value from 2019 to 2031]:
• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment
Lung Cancer Surgery Market in India by Surgery [Analysis by Value from 2019 to 2031]:
• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery
Lung Cancer Surgery Market in India by End Use [Analysis by Value from 2019 to 2031]:
• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others
Features of the Lung Cancer Surgery Market in India
Market Size Estimates: Lung cancer surgery in India market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Lung cancer surgery in India market size by product type, surgery, and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different product type, surgery, and end use for the lung cancer surgery in India.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery in India.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What are the major drivers influencing the growth of the lung cancer surgery market in India?
Answer: The major drivers for this market are the rising occurrence of lung cancer, the increasing consumer preference towards minimally invasive surgeries, and the growing air pollution levels.
Q2. What are the major segments for lung cancer surgery market in India?
Answer: The future of the lung cancer surgery market in India looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets.
Q3. Which lung cancer surgery market segment in India will be the largest in future?
Answer: Lucintel forecasts that surgical device is expected to witness the highest growth over the forecast period.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 10 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market in India by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), and end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Lung Cancer Surgery Market in India, Lung Cancer Surgery Market in India Size, Lung Cancer Surgery Market in India Growth, Lung Cancer Surgery Market in India Analysis, Lung Cancer Surgery Market in India Report, Lung Cancer Surgery Market in India Share, Lung Cancer Surgery Market in India Trends, Lung Cancer Surgery Market in India Forecast, Lung Cancer Surgery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.